An update on publicly funded multisite trials in pediatric psychopharmacology

Area of Science:

• Child and Adolescent Psychiatry
• Clinical Psychology
• Neuroscience

Background:

• The National Institute of Mental Health (NIMH) has significantly invested in multisite clinical trials for pediatric psychopharmacology over the past decade.
• These trials address a range of conditions including ADHD, depression, autism, schizophrenia, bipolar disorder, OCD, and anxiety disorders.

Purpose of the Study:

• To provide an overview of NIMH-funded multisite clinical trials in pediatric psychopharmacology.
• To summarize research comparing pharmacotherapy and psychotherapy, alone or in combination, for pediatric mental health conditions.
• To inform clinicians and families about the relative benefits of different treatment interventions.

Main Methods:

• Review of NIMH-funded multisite clinical trials in pediatric psychopharmacology.
• Analysis of studies comparing pharmacotherapy and psychotherapy interventions.
• Inclusion of trials for various pediatric mental health disorders.

Main Results:

• Multiple trials have been completed or are ongoing in key areas of child mental health.
• Studies are actively comparing the efficacy of different treatment modalities.
• Research aims to guide clinical decision-making for pediatric mental health interventions.

Conclusions:

• NIMH-funded research is advancing the understanding of pediatric psychopharmacology.
• Comparative effectiveness research is crucial for evidence-based treatment selection.
• These trials provide valuable data for clinicians and families managing childhood mental health disorders.